Dutch sector specialist Gilde Healthcare announces two new hires to its private equity team in Germany, following the recent close of its new €518m lower mid-market fund Gilde Healthcare Private Equity IV.

With the recruitment of Martin von Berg as Investment Manager and Lara Hilgert as Investment Analyst, the firm continues to expand its team in the region, following the arrival Robert Stein as Partner in 2021. Before joining Gilde Healthcare, Martin gained more than 5 years of private equity experience at 3i and Halder, where he was involved in healthcare services transactions. Martin started his career in the investment banking team of Bank of America in Frankfurt after graduating from the University of Mannheim with a MSc in Management. Lara joins Gilde Healthcare after finishing her MSc in Management at the London School of Economics. She successfully completed an internship at Gilde Healthcare last year and gained additional working experience at Roland Berger, Greenhill and PWC.

Gilde Healthcare completed four private equity transactions in Germany in the last 18 months and considers additional hires in the coming period.

About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €1.9 billion across two fund strategies: Private Equity and Venture&Growth. The firm is headquartered in Utrecht (The Netherlands) with local offices in Frankfurt (Germany) and Cambridge (United States). The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. The Private Equity fund targets healthcare providers, suppliers of medical products and service providers to pharma, medtech and healthcare. Gilde Healthcare’s Venture&Growth fund invests in therapeutics, medtech and healthtech in Europe and North America. Further information at www.gildehealthcare.com